Back
Speaker illustration

undefined undefined undefined

Presentations

Effects of doxorubicin and ibrutinib on atrial arrhythmogenity: ex-vivo assessment in human myocardium

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Arrhythmia mechanisms

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources